Premium
Prevalence of CAM deformity and its influence on therapy success in patients with osteonecrosis of the femoral head
Author(s) -
Serong Sebastian,
Haversath Marcel,
Jäger Marcus,
Landgraeber Stefan
Publication year - 2019
Publication title -
journal of tissue engineering and regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.835
H-Index - 72
eISSN - 1932-7005
pISSN - 1932-6254
DOI - 10.1002/term.2794
Subject(s) - medicine , femoroacetabular impingement , femoral head , hazard ratio , deformity , proportional hazards model , surgery , cohort , confidence interval
Osteonecrosis of the femoral head (ONFH) and CAM‐type femoroacetabular impingement (FAI) present two different pathologies of the hip joint. The aim of this study is to describe the prevalence of CAM‐FAI in a collective of ONFH hips and to evaluate its influence on ONFH therapy outcome. A cohort of 86 ONFH hips with a mean follow‐up of 46.7 months (±20.5) after advanced core decompression (ACD) was evaluated regarding CAM deformity by measuring the alpha angle (α) and head–neck offset. The influence of CAM‐type FAI was investigated using the Kaplan–Meier estimator and the Cox regression model. The mean α was 60.4° (±13.8) with 41 hips (47.7%) being ≥60°. The mean head–neck offset was 4.5 mm (±3.2), with 78 hips (90.7%) being ≤9 mm. Survival analysis indicated noticeably better ACD results for α < 60° versus α ≥ 60° ( p = 0.07). Treatment failure within the first 2 years was statistically estimated as 27.7% for α < 60° versus 40.7% for α ≥ 60°: The hazard ratio for α ≥ 60° was 1.94. Head–neck offset‐dependent survival showed better, though not significant, results for offset >9 mm ( p = 0.38, hazard ratio 1.89 for offsets ≤9 mm). The prevalence of CAM‐type deformity is greatly increased in patients with concomitant ONFH. There is a strong indication that CAM‐type FAI has a negative influence on ONFH therapy outcome. The risk that ONFH treatment will fail seems to be twice as high for α ≥ 60° as for α < 60°. We recommend cotreatment of pathological head–neck offset in patients with ONFH.